Wogonin Induces Cell Cycle Arrest and Apoptosis of Hepatocellular Carcinoma Cells by Activating Hippo Signaling. 2022

Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
Department of Cell Biology, School of Medicine of Yangzhou University, Yangzhou, Jiangsu, China.

Wogonin has been reported to exhibit pharmacological effects against cancer by regulating cell proliferation, metastasis and apoptosis, however, the role of wogonin in hepatocellular carcinoma (HCC) remains poorly elucidated. The current study aimed to illustrate whether wogonin influences HCC cell cycle progression and apoptosis by regulating Hippo signaling. The effects of wogonin on HCC cell viability, cell cycle progression and apoptosis were analyzed by utilizing CCK-8 and flow cytometry. RNA-seq was employed to analyze the expression profiles between wogonin-treated and control HCC cells, and the selected RNA-seq transcripts were validated by Reverse Transcription-quantitative realtime Polymerase Chain Reaction (RT-qPCR). Immunofluorescence staining was performed to detect the distribution of YAP/TAZ in the nucleus and cytoplasm in HCC cells. Western blotting and human apoptosis array were performed to examine the expression of the indicated genes. We demonstrated that wogonin induced cell cycle arrest and apoptosis of HCC cell lines SMMC7721 and HCCLM3. RNA-seq analysis showed enrichment in genes associated with cell cycle progression and apoptosis following incubation with wogonin in HCC cells, and the pathways analysis further identified that Hippo signaling pathways highly altered in wogonin-treated cells. Specifically, wogonin increased the phosphorylation of MOB1 and LATS1, promoted translocation of endogenous YAP and TAZ from the nucleus to the cytoplasm, and facilitated phosphorylation of YAP and TAZ. Notably, overexpression of YAP or TAZ partially abrogated the wogonin-mediated HCC cell cycle arrest and apoptosis, and reversed wogonin-mediated suppression of Claspin. Wogonin induced HCC cell cycle arrest and apoptosis probably by activating MOB1-LATS1 signaling to inhibit the activation of YAP and TAZ, and then decrease the expression of Claspin, suggesting that the understanding of the molecular mechanisms underlying wogonin-induced cell cycle arrest and apoptosis may be useful in HCC therapeutics.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090683 Hippo Signaling Pathway A signaling pathway that plays a key role in regulating tissue and organ growth. The name derives from the protein kinase Hippo (Hpo) found in DROSOPHILA; where mutations of the Hpo gene result in tissue overgrowth and the hippopotamus phenotype. Hippo Pathway,Hippo Signaling,Hippo Signaling Pathways,Signaling Pathway, Hippo
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases
D044950 Flavanones A group of FLAVONOIDS characterized with a 4-ketone. 2-Phenyl-Benzopyran-4-Ones,2 Phenyl Benzopyran 4 Ones
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
March 2012, Oncology reports,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
February 2015, Oncology reports,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
January 2008, The American journal of Chinese medicine,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
July 2011, Journal of agricultural and food chemistry,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
August 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
May 2014, Pharmaceutical biology,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
November 2012, Cellular signalling,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
January 2015, OncoTargets and therapy,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
November 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Keyan Wu, and Man Teng, and Wei Zhou, and Fanglin Lu, and Yang Zhou, and Jing Zeng, and Jie Yang, and Xinnong Liu, and Yu Zhang, and Yanbing Ding, and Weigan Shen
October 2013, Pathology oncology research : POR,
Copied contents to your clipboard!